To Investigate the Influence of Ethnicity in Metabolic Disease in Healthy, Overweight and Obese Subjects
SAMS-1
Developmental Pathways to Metabolic Diseases: Metabolic Physiology, Epigenetics and Body Composition in Healthy Overweight and Obese Subjects With a Fixed Range of Body Mass Index in Singapore - To Investigate the Influence of Ethnicity
1 other identifier
observational
200
1 country
1
Brief Summary
The overall objective of this study is to investigate in depth the nature of metabolic physiology, body composition and epigenetic differences of the different phenotypes of overweight and obese individuals who are otherwise overtly healthy among the three major ethnic groups in Singapore.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 1, 2009
CompletedFirst Posted
Study publicly available on registry
October 2, 2009
CompletedMarch 2, 2010
February 1, 2010
October 1, 2009
February 28, 2010
Conditions
Study Arms (1)
No treatment
Eligibility Criteria
Singapore population
You may qualify if:
- Ability to give informed consent
- Chinese, Malay or Indian males (aged 21-40)
- Body mass index between 23-30 kg/m2 for the overweight or obese subjects and between 18.5 to 22.9 kg/m2 for the Chinese control group
- Sedentary adults \< 1 episode of exercise \> =30 min/week
- Birth weight between 3-97% percentiles
- Fasting glucose \< 7 mmol/L
- Normotensive, defined as BP \< 140/90 mmHg and not on any antihypertensive agents
You may not qualify if:
- Recent changes in weight of \> 5% over the past 6 months
- Attempts to lose weight (weight not reaching equilibrium, exercises still changing and not in maintenance phase) over the past 6 months
- Significant changes in diet over the past 6 months
- Any use of weight reducing drugs in the past 6 months
- Previous abdominal surgery (and bariatric surgery)
- Any bleeding disorders which would preclude biopsies
- Any use of investigational drugs in the past 6 months
- Known allergy to insulin or local anesthetics
- Known allergy to milk or milk products (eg. Ensure)
- Any serious illness requiring hospitalization or surgery in the past 6 months
- Treatment with medications for hypertension, diabetes mellitus or dyslipidemia, epilepsy, ischemic heart disease
- On anti-platelet agents, non-steroidal anti-inflammatory drugs (NSAIDs) or anticoagulants
- Use of any prescription medication that cannot be safely discontinued within 14 days prior to study entry
- Any use of corticosteroids in the past 6 months
- Any other medications that could alter insulin resistance
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Singapore, Singapore
Related Publications (2)
Tan ALM, Langley SR, Tan CF, Chai JF, Khoo CM, Leow MK, Khoo EYH, Moreno-Moral A, Pravenec M, Rotival M, Sadananthan SA, Velan SS, Venkataraman K, Chong YS, Lee YS, Sim X, Stunkel W, Liu MH, Tai ES, Petretto E. Ethnicity-Specific Skeletal Muscle Transcriptional Signatures and Their Relevance to Insulin Resistance in Singapore. J Clin Endocrinol Metab. 2019 Feb 1;104(2):465-486. doi: 10.1210/jc.2018-00309.
PMID: 30137523DERIVEDLee Y, Chong MF, Liu JC, Libedinsky C, Gooley JJ, Chen S, Wu T, Tan V, Zhou M, Meaney MJ, Lee YS, Chee MW. Dietary disinhibition modulates neural valuation of food in the fed and fasted states. Am J Clin Nutr. 2013 May;97(5):919-25. doi: 10.3945/ajcn.112.053801. Epub 2013 Apr 3.
PMID: 23553164DERIVED
Biospecimen
plasma, serum, packed cells, blood clot, urine, buccal cells, muscle tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
E Shyong Tai
National University Hospital, Singapore
- PRINCIPAL INVESTIGATOR
Yung Seng Lee
National University Hospital, Singapore
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 1, 2009
First Posted
October 2, 2009
Study Start
July 1, 2009
Last Updated
March 2, 2010
Record last verified: 2010-02